R&D Partner Content Rapafusyn's Dr. Rick Ewing Acknowledged With Dual Honors For... Baltimore, MD – February 5, 2024 – Rapafusyn proudly announces the distinguished recognition of Dr.
News FDA declines to approve AbbVie's Botox follow-up AbbVie's bid to bring a rapid and shorter-acting botulinum toxin product to the US market has been knocked back by the FDA.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.